Tender Detail

A Procurement notice has been published for Oh-Biologika-2023-17-Bevacizumab in Germany. The notice will be closed on 31 July 2025. Bidsinfo Reference No. is 14263888.

14263888
Oh-Biologika-2023-17-Bevacizumab
Login to View the Company Name
Login to View Contact Details
Login to View More Details of the Tender
Germany
2025-07-31
Original Tender Notice / Documents
Login to View Full Detail
Buy this Tender

Related Tenders

Ghana Clindamycin Inj,150mg/Ml in 2 Ml

Expire on 2025-01-10

Germany Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V for Medicinal Products with the Active Ingredient Sapropteri

Expire on 2024-11-10

Germany Completion of Non-Exclusive Discount Contracts in Accordance with Sections 130a (8/11) Sgb V for Medicinal Products with the Active Ingredient Apremilast (L04aa32) as Part of a so-Called Open House Model.

Expire on 2025-07-31

Germany Open House Original Discount Contracts 2023-17 - Empagliflozin

Expire on 2025-06-30

Germany Completion of Non-Exclusive Discount Agreements According to Section 130a (8) Sgb V to the in Ii.2.4. Mentioned Active Ingredients with a Final Option in the Context of the so-Called Open House Process.

Expire on 2025-12-31

Germany Completion of Non-Exclusive Discount Agreements According to Section 130a (8) Sgb V to the Active Ingredient Evolocumab

Expire on 2025-02-10

View more

Tenders from Germany

Germany Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V for Medicinal Products with the Active Ingredient Sapropteri

Expire on 2024-11-10

Germany Completion of Non-Exclusive Discount Contracts in Accordance with Sections 130a (8/11) Sgb V for Medicinal Products with the Active Ingredient Apremilast (L04aa32) as Part of a so-Called Open House Model.

Expire on 2025-07-31

Germany Open House Original Discount Contracts 2023-17 - Empagliflozin

Expire on 2025-06-30

Germany Completion of Non-Exclusive Discount Agreements According to Section 130a (8) Sgb V to the in Ii.2.4. Mentioned Active Ingredients with a Final Option in the Context of the so-Called Open House Process.

Expire on 2025-12-31

Germany Completion of Non-Exclusive Discount Agreements According to Section 130a (8) Sgb V to the Active Ingredient Evolocumab

Expire on 2025-02-10

Germany Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V for Medicinal Products with the Active Ingredient Teriflunomide

Expire on 2024-11-10

View more

Latest Tenders

Digimarc Corporation Launches Industry's Most Advanced Anti-Counterfeit Technology to Safeguard Government Programs, Businesses, and Citizens

Expire on 0000-00-00

Accenture Invests in Cresta to Improve Contact Center Efficiency

Expire on 0000-00-00

Microsoft expands custom silicon with new DPU, data centre security chips

Expire on 0000-00-00

Dynatrace Joins the Microsoft Intelligent Security Association

Expire on 0000-00-00

India Realignment of 1 Km Long 12.75 Inch Od Pajpl from Pajpl Ch.49.000-50.000 Km across Humkhad Nala through Single Hdd

Expire on 2024-12-12

India Empanelment for Provision of Onboard Catering Services in Various Types of Trains on Indian Railways

Expire on 2024-12-06

View more

Quick Links

Tenders by Country

Tenders by Industry

Tenders by Region

Tenders by Funding Agency

Get In Touch


Copyright © 2012-2024, Biztech Global Data Point Pvt. Ltd., All Rights Reserved.